Serum complement activity, immunoglobulin levels and the circulating auto-antibodies were studied in the course of laser treatment of 20 cases of crural ulcer. After temporary changes a normalization of the humoral immune response was observed in the healing cases, while in the stagnating ones opposite trend was manifest. In none of the groups were detected circulating auto-antibodies against the investigated antigens.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Interpreting high levels of unfolded Von Willebrand Factor in patients with the antiphospholipid syndrome.
Front Immunol
December 2024
Coagulation Laboratory, Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Introduction: Unfolded Von Willebrand Factor (VWF) is increased in thrombotic pathologies such as myocardial infarction. Unfolded VWF mediates the binding of platelets without the need for collagen. β-glycoprotein I (β-GPI) is a natural inhibitor of the platelet-VWF interaction.
View Article and Find Full Text PDFUse of multivariant enzyme-linked immunosorbent assay (ELISA) in the diagnosis of autoimmune bullous disorders in a resource-limited setting: A single-center experience.
Indian J Dermatol Venereol Leprol
November 2024
Department of Dermatology, Venerology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Article Synopsis
- Autoimmune blistering disorders (AIBD) are conditions where the body produces auto-antibodies against adhesion proteins in the skin, detectable through direct immunofluorescence (DIF) or blood tests like ELISA.
- This study aimed to assess how well the results from a new multivariant ELISA method agreed with AIBD diagnoses established from clinical assessments, histopathology, and DIF.
- The results showed a good overall correlation between ELISA and diagnoses, particularly strong in pemphigus vulgaris, but with variable agreement levels in other types of AIBD and limitations due to the retrospective nature of the study.
Similar Kinetics of Pulmonary SARS-CoV-2 Load in Intensive Care Unit Patients with COVID-19 Pneumonia with or Without Autoantibodies Neutralizing Type I Interferons.
J Clin Immunol
November 2024
Médecine Intensive Réanimation, Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Purpose: The pathogenesis of life-threatening coronavirus disease 2019 (COVID-19) pneumonia in ICU patients can involve pre-existing auto-antibodies (auto-Abs) neutralizing type I interferons (IFNs). The impact of these auto-Abs on SARS-CoV-2 clearance in the lower respiratory tract (LRT) is unclear.
Methods: We performed a retrospective study in 99 ICU patients with COVID-19 pneumonia between March and May 2020.
[Neonatal Fc receptor : role and implications in maternal fetal medicine].
Rev Med Suisse
October 2024
Service d'hématologie, Centre hospitalier universitaire vaudois et Université de Lausanne, 1011 Lausanne.
During pregnancy, the mother's IgG immunoglobulins cross the -placenta via the neonatal Fc receptor (FcRn), enabling the fetus to acquire passive immunity. In the presence of maternal allo- or auto-antibodies, placental transfer of these pathogenic antibodies mediated by FcRn can cause diseases in the fetus and/or the newborn. FcRn blockade therefore appears to be a therapeutic strategy in these high-risk pregnancies, firstly by reducing IgG recycling, -thereby reducing its concentration in the maternal circulation, and secondly by blocking placental transfer.
View Article and Find Full Text PDFLong COVID syndrome: An unfolding enigma.
Indian J Med Res
June 2024
Department of Molecular Medicine, Jamia Hamdard Institute of Molecular Medicine, New Delhi, India.
Article Synopsis
- Long COVID, a condition affecting individuals after recovering from COVID-19, presents a range of symptoms that can persist for weeks to months, regardless of the initial severity of the illness.
- Risk factors for developing long COVID include older age, female gender, and pre-existing health conditions, with symptoms like fatigue, cognitive impairment, and respiratory issues affecting about 10-20% of patients, mainly reported in high-income countries.
- While there are currently no definitive lab tests for diagnosing long COVID, emerging biomarkers and rehabilitation strategies are essential for managing the condition, alongside vaccination and early antiviral treatments to help prevent its onset.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!